Pacific Biosciences of California Inc (PACB)
8.52
+0.14
(+1.67%)
USD |
NASDAQ |
Dec 08, 12:03
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.279B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -9.89% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 12.23 |
| Price to Book Value | 2.984 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 1.168 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 92.33% |
Profile
| Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe. |
| URL | https://www.pacb.com |
| Investor Relations URL | https://investor.pacificbiosciences.com |
| HQ State/Province | California |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Feb. 16, 2024 (est.) |
| Last Earnings Release | Oct. 30, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe. |
| URL | https://www.pacb.com |
| Investor Relations URL | https://investor.pacificbiosciences.com |
| HQ State/Province | California |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Feb. 16, 2024 (est.) |
| Last Earnings Release | Oct. 30, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |